To determine whether administration of recombinant ISG15 could suppress tumor progression in mice, ID8 tumor-bearing C57BL/6 mice were treated with purified recombinant mouse ISG15 protein (1 mg/mL) through intraperitoneal injection. Here, ISG15 is linked to neoplasm.